Regulatory Challenges
Navigating the regulatory landscape can be complex, as the FDA offers a unique 510K submission pathway that can expedite approvals, while Health Canada lacks a similar system, leading to longer timelines. Fundraising in the medtech space presents its own hurdles, particularly in Canada, where investors tend to be more risk-averse. The experience highlights the influence of U.S. investors on Canadian funding dynamics, as local investors often follow suit when they sense momentum from their U.S. counterparts.In this clip
From this podcast
The Hard Part with Evan McCann
Inara Lalani from FemTherapeutics
Related Questions